{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:48:59Z","timestamp":1792014539042,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474269"],"award-info":[{"award-number":["82474269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574748"],"award-info":[{"award-number":["82574748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170747"],"award-info":[{"award-number":["82170747"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305095"],"award-info":[{"award-number":["82305095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation from Shanghai Municipal Commission of Health_Departments","award":["201740193"],"award-info":[{"award-number":["201740193"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["No. ZXS004R4-1"],"award-info":[{"award-number":["No. ZXS004R4-1"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["No. ZD2021CY001"],"award-info":[{"award-number":["No. ZD2021CY001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chronic kidney disease (CKD) is a leading cause of global morbidity. The kidney is a major gluconeogenic organ, and impaired renal gluconeogenesis contributes to CKD, yet the regulatory mechanisms remain poorly understood. Here we show that enhancer of zeste homolog 2 (EZH2), a histone H3K27 trimethyltransferase, epigenetically suppresses renal gluconeogenesis and drives tubulointerstitial fibrosis. Through integrative multi-omics profiling (RNA-seq, CUT&amp;Tag, and single-nucleus RNA-seq), we show that EZH2 directly binds to and deposits H3K27 trimethylation at promoters of gluconeogenic genes in proximal tubular cells, with the most prominent repression observed at phosphoenolpyruvate carboxykinase (\n                    <jats:italic>Pck1<\/jats:italic>\n                    ) gene. In fibrotic kidneys,\n                    <jats:italic>Ezh2<\/jats:italic>\n                    is markedly upregulated in proximal tubules and inversely correlates with\n                    <jats:italic>Pck1<\/jats:italic>\n                    expression across injury and maladaptive repair states. Genetic ablation or pharmacological inhibition of EZH2 restores PCK1 expression, enhances lactate-to-glucose conversion, and attenuates extracellular matrix deposition and fibrotic marker expression in both cultured tubular cells and mouse models of kidney fibrosis. Stable isotope\n                    <jats:sup>13<\/jats:sup>\n                    C-lactate tracing shows that tubular\n                    <jats:italic>Ezh2<\/jats:italic>\n                    deletion increases the labelling fractions of gluconeogenic intermediates while reducing the labelling fraction of acetyl-CoA, indicating preferential partitioning of lactate-derived carbon towards gluconeogenesis rather than oxidative entry into the tricarboxylic acid (TCA) cycle in vivo. Mechanistically,\n                    <jats:italic>Pck1<\/jats:italic>\n                    gain- and loss-of-function experiments establish PCK1 as a non-redundant downstream effector of EZH2\u2019s pro-fibrotic action. Collectively, our findings uncover an EZH2\u2013PCK1 epigenetic\u2013metabolic axis that couples histone methylation to gluconeogenic reprogramming and fibrogenesis. This axis may offer a dual therapeutic opportunity for CKD by concurrently restoring metabolic homeostasis and limiting fibrotic progression.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00617-y","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:10:34Z","timestamp":1792012234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetically silencing gluconeogenic enzyme PCK1 by EZH2 promotes renal tubulointerstitial fibrosis"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-8766","authenticated-orcid":false,"given":"Ming","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinglan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro E.","family":"Cipp\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"6","key":"617_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41581-026-01056-2","volume":"22","author":"C Combe","year":"2026","unstructured":"Combe C, Alencar de Pinho N, Guedes M, Frimat L, Fouque D, Liabeuf S, et al. Optimal patient care in advanced chronic kidney disease progressing to kidney failure. Nat Rev Nephrol. 2026;22(6):406\u201321. https:\/\/doi.org\/10.1038\/s41581-026-01056-2.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"617_CR2","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1159\/000552776","volume":"51","author":"JA Schoonmaker","year":"2026","unstructured":"Schoonmaker JA, Bhasin-Chhabra B, Abow Alkhier A, Swaminathan S, Hommos MS. Drugs to slow progression of chronic kidney disease: it is a whole new world! Kidney Blood Press Res. 2026;51(1):530\u201341. https:\/\/doi.org\/10.1159\/000552776.","journal-title":"Kidney Blood Press Res"},{"key":"617_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.matbio.2018.02.006","volume":"68-69","author":"LS Gewin","year":"2018","unstructured":"Gewin LS. Renal fibrosis: primacy of the proximal tubule. Matrix Biol. 2018;68\u201369:248\u201362. https:\/\/doi.org\/10.1016\/j.matbio.2018.02.006.","journal-title":"Matrix Biol"},{"issue":"1","key":"617_CR4","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1152\/ajprenal.00164.2016","volume":"311","author":"RL Chevalier","year":"2016","unstructured":"Chevalier RL. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Renal Physiol. 2016;311(1):F145\u201361. https:\/\/doi.org\/10.1152\/ajprenal.00164.2016.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"617_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1053\/j.ackd.2016.11.011","volume":"24","author":"HW Schnaper","year":"2017","unstructured":"Schnaper HW. The tubulointerstitial pathophysiology of progressive kidney disease. Adv Chronic Kidney Dis. 2017;24(2):107\u201316. https:\/\/doi.org\/10.1053\/j.ackd.2016.11.011.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"617_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/CS20201213","volume":"135","author":"CC Gifford","year":"2021","unstructured":"Gifford CC, Tang J, Costello A, Khakoo NS, Nguyen TQ, Goldschmeding R, et al. Negative regulators of TGF-beta1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities. Clin Sci (Lond). 2021;135(2):275\u2013303. https:\/\/doi.org\/10.1042\/CS20201213.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"617_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41581-024-00889-z","volume":"21","author":"V Miguel","year":"2025","unstructured":"Miguel V, Shaw IW, Kramann R. Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease. Nat Rev Nephrol. 2025;21(1):39\u201356. https:\/\/doi.org\/10.1038\/s41581-024-00889-z.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"617_CR8","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/ndt\/gfaa302","volume":"37","author":"D Legouis","year":"2022","unstructured":"Legouis D, Faivre A, Cippa PE, de Seigneux S. Renal gluconeogenesis: an underestimated role of the kidney in systemic glucose metabolism. Nephrol Dial Transplant. 2022;37(8):1417\u201325. https:\/\/doi.org\/10.1093\/ndt\/gfaa302.","journal-title":"Nephrol Dial Transplant"},{"key":"617_CR9","doi-asserted-by":"publisher","first-page":"742072","DOI":"10.3389\/fmed.2021.742072","volume":"8","author":"A Faivre","year":"2021","unstructured":"Faivre A, Verissimo T, Auwerx H, Legouis D, de Seigneux S. Tubular cell glucose metabolism shift during acute and chronic injuries. Front Med (Lausanne). 2021;8:742072. https:\/\/doi.org\/10.3389\/fmed.2021.742072.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"617_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1681\/ASN.2021050680","volume":"33","author":"T Verissimo","year":"2022","unstructured":"Verissimo T, Faivre A, Rinaldi A, Lindenmeyer M, Delitsikou V, Veyrat-Durebex C, et al. Decreased renal gluconeogenesis is a hallmark of chronic kidney disease. J Am Soc Nephrol. 2022;33(4):810\u201327. https:\/\/doi.org\/10.1681\/ASN.2021050680.","journal-title":"J Am Soc Nephrol"},{"key":"617_CR11","doi-asserted-by":"publisher","first-page":"640700","DOI":"10.3389\/fphys.2021.640700","volume":"12","author":"T Li","year":"2021","unstructured":"Li T, Yu C, Zhuang S. Histone methyltransferase EZH2: a potential therapeutic target for kidney diseases. Front Physiol. 2021;12:640700. https:\/\/doi.org\/10.3389\/fphys.2021.640700.","journal-title":"Front Physiol"},{"issue":"3","key":"617_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.kint.2024.10.031","volume":"107","author":"I Mimura","year":"2025","unstructured":"Mimura I, Chen Z, Natarajan R. Epigenetic alterations and memory: key players in the development\/progression of chronic kidney disease promoted by acute kidney injury and diabetes. Kidney Int. 2025;107(3):434\u201356. https:\/\/doi.org\/10.1016\/j.kint.2024.10.031.","journal-title":"Kidney Int"},{"issue":"1","key":"617_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan R, Du W, Guo W. EZH2: a novel target for cancer treatment. J Hematol Oncol. 2020;13(1):104. https:\/\/doi.org\/10.1186\/s13045-020-00937-8.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"617_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12943-023-01786-y","volume":"22","author":"J Chen","year":"2023","unstructured":"Chen J, Hong JH, Huang Y, Liu S, Yin J, Deng P, et al. EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer. Mol Cancer. 2023;22(1):85. https:\/\/doi.org\/10.1186\/s12943-023-01786-y.","journal-title":"Mol Cancer"},{"key":"617_CR15","doi-asserted-by":"publisher","unstructured":"Harirah HAA, Mohammed MH, Basha SAZ, Uthirapathy S, Ganesan S, Shankhyan A, et al. Targeting EZH2 in autoimmune diseases: unraveling epigenetic regulation and therapeutic potential. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(9):11519\u201339. https:\/\/doi.org\/10.1007\/s00210-025-04127-6.","DOI":"10.1007\/s00210-025-04127-6"},{"issue":"11","key":"617_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41419-018-1012-0","volume":"9","author":"X Zhou","year":"2018","unstructured":"Zhou X, Zang X, Guan Y, Tolbert T, Zhao TC, Bayliss G, et al. Targeting enhancer of zeste homolog 2 protects against acute kidney injury. Cell Death Dis. 2018;9(11):1067. https:\/\/doi.org\/10.1038\/s41419-018-1012-0.","journal-title":"Cell Death Dis"},{"issue":"1","key":"617_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s43556-025-00276-5","volume":"6","author":"Q Xia","year":"2025","unstructured":"Xia Q, Xu F, Zhang L, Ding W, Liu J, Liu J, et al. The EZH2 selective inhibitor ZLD1039 attenuates UUO-induced renal fibrosis by suppressing YAP activation. Mol Biomed. 2025;6(1):36. https:\/\/doi.org\/10.1186\/s43556-025-00276-5.","journal-title":"Mol Biomed"},{"issue":"1","key":"617_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s42003-025-07735-3","volume":"8","author":"Y Xia","year":"2025","unstructured":"Xia Y, Ye Z, Li B, Yan X, Yuan T, Li L, et al. EZH2-mediated macrophage-to-myofibroblast transition contributes to calcium oxalate crystal-induced kidney fibrosis. Commun Biol. 2025;8(1):286. https:\/\/doi.org\/10.1038\/s42003-025-07735-3.","journal-title":"Commun Biol"},{"issue":"4","key":"617_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1158\/0008-5472.CAN-19-2060","volume":"80","author":"K Liao","year":"2020","unstructured":"Liao K, Deng S, Xu L, Pan W, Yang S, Zheng F, et al. A feedback circuitry between polycomb signaling and fructose-1, 6-bisphosphatase enables hepatic and renal tumorigenesis. Cancer Res. 2020;80(4):675\u201388. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2060.","journal-title":"Cancer Res"},{"key":"617_CR20","doi-asserted-by":"publisher","first-page":"9174926","DOI":"10.1155\/2018\/9174926","volume":"2018","author":"ZL Shi","year":"2018","unstructured":"Shi ZL, Fang K, Li ZH, Ren DH, Zhang JY, Sun J. EZH2 inhibition ameliorates transverse aortic constriction-induced pulmonary arterial hypertension in mice. Can Respir J. 2018;2018:9174926. https:\/\/doi.org\/10.1155\/2018\/9174926.","journal-title":"Can Respir J"},{"issue":"11","key":"617_CR21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nchembio.1084","volume":"8","author":"SK Knutson","year":"2012","unstructured":"Knutson SK, Wigle TJ, Warholic NM, Sneeringer CJ, Allain CJ, Klaus CR, et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol. 2012;8(11):890\u20136. https:\/\/doi.org\/10.1038\/nchembio.1084.","journal-title":"Nat Chem Biol"},{"issue":"9","key":"617_CR22","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.2337\/db16-1602","volume":"66","author":"M Sasaki","year":"2017","unstructured":"Sasaki M, Sasako T, Kubota N, Sakurai Y, Takamoto I, Kubota T, et al. Dual regulation of gluconeogenesis by insulin and glucose in the proximal tubules of the kidney. Diabetes. 2017;66(9):2339\u201350. https:\/\/doi.org\/10.2337\/db16-1602.","journal-title":"Diabetes"},{"issue":"2","key":"617_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1172\/JCI130038","volume":"130","author":"C Luo","year":"2020","unstructured":"Luo C, Balsa E, Perry EA, Liang J, Tavares CD, Vazquez F, et al. H3K27me3-mediated PGC1alpha gene silencing promotes melanoma invasion through WNT5A and YAP. J Clin Invest. 2020;130(2):853\u201362. https:\/\/doi.org\/10.1172\/JCI130038.","journal-title":"J Clin Invest"},{"issue":"3","key":"617_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.15283\/ijsc22046","volume":"16","author":"W Qin","year":"2023","unstructured":"Qin W, Yang L, Chen X, Ye S, Liu A, Chen D, et al. Wedelolactone promotes the chondrogenic differentiation of mesenchymal stem cells by suppressing EZH2. Int J Stem Cells. 2023;16(3):326\u201341. https:\/\/doi.org\/10.15283\/ijsc22046.","journal-title":"Int J Stem Cells"},{"issue":"4","key":"617_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","volume":"27","author":"GA Brooks","year":"2018","unstructured":"Brooks GA. The science and translation of lactate shuttle theory. Cell Metab. 2018;27(4):757\u201385. https:\/\/doi.org\/10.1016\/j.cmet.2018.03.008.","journal-title":"Cell Metab"},{"issue":"1","key":"617_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, et al. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022;7(1):305. https:\/\/doi.org\/10.1038\/s41392-022-01151-3.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"617_CR27","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00125-024-06156-x","volume":"67","author":"J Chen","year":"2024","unstructured":"Chen J, Feng Q, Qiao Y, Pan S, Liang L, Liu Y, et al. ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes. Diabetologia. 2024;67(7):1429\u201343. https:\/\/doi.org\/10.1007\/s00125-024-06156-x.","journal-title":"Diabetologia"},{"issue":"28","key":"617_CR28","doi-asserted-by":"publisher","first-page":"e2307216","DOI":"10.1002\/advs.202307216","volume":"11","author":"J Qiao","year":"2024","unstructured":"Qiao J, Tan Y, Liu H, Yang B, Zhang Q, Liu Q, et al. Histone H3K18 and ezrin lactylation promote renal dysfunction in sepsis-associated acute kidney injury. Adv Sci (Weinh). 2024;11(28):e2307216. https:\/\/doi.org\/10.1002\/advs.202307216.","journal-title":"Adv Sci (Weinh)"},{"key":"617_CR29","doi-asserted-by":"publisher","first-page":"103246","DOI":"10.1016\/j.redox.2024.103246","volume":"75","author":"X Zhang","year":"2024","unstructured":"Zhang X, Chen J, Lin R, Huang Y, Wang Z, Xu S, et al. Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la\/KLF5 pathway. Redox Biol. 2024;75:103246. https:\/\/doi.org\/10.1016\/j.redox.2024.103246.","journal-title":"Redox Biol"},{"issue":"2","key":"617_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.kint.2024.04.016","volume":"106","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li H, Jiang S, Fu D, Lu X, Lu M, et al. The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-kappaB family activation. Kidney Int. 2024;106(2):226\u201340. https:\/\/doi.org\/10.1016\/j.kint.2024.04.016.","journal-title":"Kidney Int"},{"issue":"1","key":"617_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.gendis.2022.02.010","volume":"10","author":"J Xiang","year":"2023","unstructured":"Xiang J, Wang K, Tang N. PCK1 dysregulation in cancer: metabolic reprogramming, oncogenic activation, and therapeutic opportunities. Genes Dis. 2023;10(1):101\u201312. https:\/\/doi.org\/10.1016\/j.gendis.2022.02.010.","journal-title":"Genes Dis"},{"key":"617_CR32","doi-asserted-by":"publisher","first-page":"1196226","DOI":"10.3389\/fcell.2023.1196226","volume":"11","author":"Y Yu","year":"2023","unstructured":"Yu Y, Li J, Ren K. Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy. Front Cell Dev Biol. 2023;11:1196226. https:\/\/doi.org\/10.3389\/fcell.2023.1196226.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"617_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/CM9.0000000000002969","volume":"137","author":"M Wu","year":"2024","unstructured":"Wu M, Wu J, Liu K, Jiang M, Xie F, Yin X, et al. LONP1 ameliorates liver injury and improves gluconeogenesis dysfunction in acute-on-chronic liver failure. Chin Med J (Engl). 2024;137(2):190\u20139. https:\/\/doi.org\/10.1097\/CM9.0000000000002969.","journal-title":"Chin Med J (Engl)"},{"issue":"50","key":"617_CR34","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1038\/s41388-021-02058-z","volume":"40","author":"R Liu","year":"2021","unstructured":"Liu R, Gou D, Xiang J, Pan X, Gao Q, Zhou P, et al. O-GlcNAc modified-TIP60\/KAT5 is required for PCK1 deficiency-induced HCC metastasis. Oncogene. 2021;40(50):6707\u201319. https:\/\/doi.org\/10.1038\/s41388-021-02058-z.","journal-title":"Oncogene"},{"issue":"12","key":"617_CR35","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41388-017-0070-6","volume":"37","author":"MX Liu","year":"2018","unstructured":"Liu MX, Jin L, Sun SJ, Liu P, Feng X, Cheng ZL, et al. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene. 2018;37(12):1637\u201353. https:\/\/doi.org\/10.1038\/s41388-017-0070-6.","journal-title":"Oncogene"},{"issue":"5","key":"617_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.kint.2025.06.018","volume":"108","author":"D Dalga","year":"2025","unstructured":"Dalga D, Rinaldi A, Fu X, Chanvillard L, Huber A, Faivre A, et al. Phosphoenolpyruvate carboxykinase 1-mediated cataplerosis is required to maintain mitochondrial fitness and to avoid kidney disease progression. Kidney Int. 2025;108(5):827\u201347. https:\/\/doi.org\/10.1016\/j.kint.2025.06.018.","journal-title":"Kidney Int"},{"issue":"1","key":"617_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11912-026-01754-x","volume":"28","author":"M Kucukoner","year":"2026","unstructured":"Kucukoner M, Demir T, Alsubaie AM, Alabalik U, Ibrahim AK, Pierobon M, et al. The role of EZH2 in malignant pleural mesothelioma and beyond: current practice and future perspectives. Curr Oncol Rep. 2026;28(1):65. https:\/\/doi.org\/10.1007\/s11912-026-01754-x.","journal-title":"Curr Oncol Rep"},{"key":"617_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2026.02.042","volume":"248","author":"Y Li","year":"2026","unstructured":"Li Y, Zhao J, Chen J, Zhou P, Zou S, Shen H, et al. Tubular EZH2 promotes acute kidney injury by Inhibiting SDHC-mediated mitochondrial function. Free Radic Biol Med. 2026;248:14\u201328. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2026.02.042.","journal-title":"Free Radic Biol Med"},{"issue":"13","key":"617_CR39","doi-asserted-by":"publisher","first-page":"e70454","DOI":"10.1002\/cncr.70454","volume":"132","author":"L Lawrence","year":"2026","unstructured":"Lawrence L. EZH2 inhibitor tazemetostat voluntarily withdrawn from market. Cancer. 2026;132(13):e70454. https:\/\/doi.org\/10.1002\/cncr.70454.","journal-title":"Cancer"},{"issue":"52","key":"617_CR40","doi-asserted-by":"publisher","first-page":"15988","DOI":"10.1073\/pnas.1521740112","volume":"112","author":"J Yin","year":"2015","unstructured":"Yin J, Leavenworth JW, Li Y, Luo Q, Xie H, Liu X, et al. Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity. Proc Natl Acad Sci U S A. 2015;112(52):15988\u201393. https:\/\/doi.org\/10.1073\/pnas.1521740112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"617_CR41","doi-asserted-by":"publisher","first-page":"eaaw3593","DOI":"10.1126\/sciadv.aaw3593","volume":"5","author":"Y Sun","year":"2019","unstructured":"Sun Y, Liu Z, Cao X, Lu Y, Mi Z, He C, et al. Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease. Sci Adv. 2019;5(6):eaaw3593. https:\/\/doi.org\/10.1126\/sciadv.aaw3593.","journal-title":"Sci Adv"},{"issue":"1","key":"617_CR42","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1038\/s41467-023-38771-4","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yang Y, Yang F, Liu X, Zhan P, Wu J, et al. HDAC9-mediated epithelial cell cycle arrest in G2\/M contributes to kidney fibrosis in male mice. Nat Commun. 2023;14(1):3007. https:\/\/doi.org\/10.1038\/s41467-023-38771-4.","journal-title":"Nat Commun"},{"issue":"6","key":"617_CR43","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1096\/fj.201802585RR","volume":"33","author":"M Wu","year":"2019","unstructured":"Wu M, Lin P, Li L, Chen D, Yang X, Xu L, et al. Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys. FASEB J. 2019;33(6):6948\u201356. https:\/\/doi.org\/10.1096\/fj.201802585RR.","journal-title":"FASEB J"},{"issue":"576","key":"617_CR44","doi-asserted-by":"publisher","first-page":"eaaz1458","DOI":"10.1126\/scitranslmed.aaz1458","volume":"13","author":"X Gu","year":"2021","unstructured":"Gu X, Yang H, Sheng X, Ko YA, Qiu C, Park J, et al. Kidney disease genetic risk variants alter lysosomal beta-mannosidase (MANBA) expression and disease severity. Sci Transl Med. 2021;13(576):eaaz1458. https:\/\/doi.org\/10.1126\/scitranslmed.aaz1458.","journal-title":"Sci Transl Med"},{"issue":"10","key":"617_CR45","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/2211-5463.12949","volume":"10","author":"M Wu","year":"2020","unstructured":"Wu M, Yuan M, Wang Y, Tan B, Huang D, Wang C, et al. Renal asymmetric dimethylarginine inhibits fibrosis. FEBS Open Bio. 2020;10(10):2003\u20139. https:\/\/doi.org\/10.1002\/2211-5463.12949.","journal-title":"FEBS Open Bio"},{"issue":"1","key":"617_CR46","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1038\/s41467-021-24712-6","volume":"12","author":"W Tonnus","year":"2021","unstructured":"Tonnus W, Meyer C, Steinebach C, Belavgeni A, von Massenhausen A, Gonzalez NZ, et al. Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury. Nat Commun. 2021;12(1):4402. https:\/\/doi.org\/10.1038\/s41467-021-24712-6.","journal-title":"Nat Commun"},{"issue":"8","key":"617_CR47","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s42255-020-0238-1","volume":"2","author":"D Legouis","year":"2020","unstructured":"Legouis D, Ricksten SE, Faivre A, Verissimo T, Gariani K, Verney C, et al. Altered proximal tubular cell glucose metabolism during acute kidney injury is associated with mortality. Nat Metab. 2020;2(8):732\u201343. https:\/\/doi.org\/10.1038\/s42255-020-0238-1.","journal-title":"Nat Metab"},{"issue":"18","key":"617_CR48","doi-asserted-by":"publisher","first-page":"e161783","DOI":"10.1172\/jci.insight.161783","volume":"7","author":"A Rinaldi","year":"2022","unstructured":"Rinaldi A, Lazareth H, Poindessous V, Nemazanyy I, Sampaio JL, Malpetti D, et al. Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury. JCI Insight. 2022;7(18):e161783. https:\/\/doi.org\/10.1172\/jci.insight.161783.","journal-title":"JCI Insight"},{"issue":"27","key":"617_CR49","doi-asserted-by":"publisher","first-page":"15874","DOI":"10.1073\/pnas.2005477117","volume":"117","author":"Y Kirita","year":"2020","unstructured":"Kirita Y, Wu H, Uchimura K, Wilson PC, Humphreys BD. Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury. Proc Natl Acad Sci U S A. 2020;117(27):15874\u201383. https:\/\/doi.org\/10.1073\/pnas.2005477117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"617_CR50","doi-asserted-by":"publisher","first-page":"e123151","DOI":"10.1172\/jci.insight.123151","volume":"3","author":"PE Cippa","year":"2018","unstructured":"Cippa PE, Sun B, Liu J, Chen L, Naesens M, McMahon AP. Transcriptional trajectories of human kidney injury progression. JCI Insight. 2018;3(22):e123151. https:\/\/doi.org\/10.1172\/jci.insight.123151.","journal-title":"JCI Insight"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00617-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:10:35Z","timestamp":1792012235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00617-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00617-y","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the Animal Ethics Committee of Shanghai University of Traditional Chinese Medicine (protocol no. PZSHUTCM18102604, 8 May 2018). The Animal Ethics Committee of Shanghai University of Traditional Chinese Medicine strictly adheres to the principles and guidelines established by the International Council for Laboratory Animal Science (ICLAS) to ensure that our animal research meets international ethical standards.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"210"}}